More articles from Oncology - Basic: Therapy, Metrics and Intervention

You have access
Prognosis of patients with carcinoid heart disease treated by peptide receptor radionuclide therapy (PRRT)
V Prasad, M.A. Secknus, D. Hoersch, T. Kuntze, C. Zachert and R.P. Baum

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1617;
You have access
Assessment of reproducibility in quantitative FDG PET and CT measurements of tumor response to therapy
H Jacene, Sophie Leboulleux, Shingo Baba, Daniel Chatzifotiadit, Karen Horton, Ihab Kamel, Oleg Teytelbaum, Katarzyna Macura, Jeanne Kowalski and Richard Wahl

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1624;
You have access
Standardized SUVmean method in FDG PET/CT: Initial experience in squamous cell carcinoma (SCC) of the head and neck
Michael Wissmeyer, Anne Benedicte Zorzini, David Crook, Charles Steiner, Habib Zaidi, Mohamed Allaoua, Jean Pierre Willi and Osman Ratib

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1622;
You have access
Prior rituximab exposure does not affect response to radioimmunotherapy for non-Hodgkin's lymphoma
D Udall, R Wahl and H Jacene

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1615;
You have access
Accuracy of shortened acquisition protocols for the quantitative assessment of the 2-tissue compartment model using dynamic PET F-18-deoxyglucose (FDG) studies
Ludwig Strauss, Leyun Pan, Caixia Cheng, Uwe Haberkorn and Antonia Dimitrakopoulou-Strauss

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 630;
You have access
Impact of quality assurance, centralized analysis, ROI method and glucose correction on SUV test-retest variability in a multi-center setting
Ronald Boellaard, Wendy Hayes, Nikie Hoetjes, Reina Kloet, Otto Hoeksta, Adriaan Lammertsma, Georgia Kollia, Susan Galbraith and Linda Velasquez

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 627;
You have access
Albumin derived peptides efficiently reduce renal uptake of radiolabeled peptides
Erik Vegt, Annemarie Eek, M. Gotthardt, Marion De jong, Wim Oyen and Otto Boerman

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 576;
You have access
Impact of deep inspiration breath hold and free breathing acquisitions on the quantification of FDG PET for lung cancer using automatic structure delineation
Sonia Scigliano, Renaud Maroy, Yoann Fontyn, Pascal Merlet, Claude Comtat and Regine Trebossen

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 629;
You have access
Combination anti-CD20 immunotherapy and pretargeted anti-CD20 radioimmunotherapy (PT-RAIT) of non-Hodgkin lymphoma (NHL) shows improved efficacy
David M. Goldenberg, Habibe Karacay, Chien-Hsing Chang, Edmund A. Rossi, William J. McBride and Robert M. Sharkey

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 574;
You have access
Therapeutic efficacy of intravesical α-radioimmunotherapy with Bi-213-anti-EGFR-MAb in a human bladder cancer nude mouse model
Birgit Pfost, Christof Seidl, Michael Autenrieth, Frank Bruchertseifer, Alfred Morgenstern and Reingard Senekowitsch-Schmidtke

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 573;

Main menu

User menu

Search

More articles from Oncology - Basic: Therapy, Metrics and Intervention

Pages